ARTICLE | Company News
Juno rises following Celgene deal
July 1, 2015 1:41 AM UTC
Juno Therapeutics Inc. (NASDAQ:JUNO) gained $7.03 (15%) to $53.33 on Tuesday after post-market news Monday that it formed a 10-year collaboration with Celgene Corp. (NASDAQ:CELG) to develop immunother...